Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

1998 • 3,550 citations

Natural history of liver fibrosis progression in patients with chronic hepatitis C

1997 • 3,027 citations

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

1998 • 2,374 citations

Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy

1998 • 2,112 citations

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

1998 • 1,318 citations

Epidemiology of hepatitis C

1997 • 1,112 citations

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1993 • 703 citations

National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C

1997 • 572 citations

Is an ?� la carte? combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?

2000 • 378 citations

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1997 • 337 citations

Effect of interferon alfa on the dynamics of hepatitis C virus turnoverin vivo

1996 • 230 citations

Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations

1998 • 199 citations

Quantification of the initial decline of serum hepatitis c virus RNA and response to interferon alfa

1998 • 171 citations

Evolution of Hepatitis C Virus Quasispecies in Hypervariable Region 1 and the Putative Interferon Sensitivity-Determining Region during Interferon Therapy and Natural Infection

1998 • 135 citations

Hepatitis C Virus Kinetics

2000 • 107 citations

Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C

1995 • 104 citations

Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT

1999 • 83 citations

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

1998 • 79 citations

Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon

1993 • 54 citations

Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin

1994 • 51 citations